🔗 Share this article

Grammy-winning R&B singer D’Angelo died on October 14 at age 51 after a private battle with pancreatic cancer.

“The shining star of our family has faded away for us in the present world,” his family stated. “After a prolonged and courageous battle with the disease, we are heartbroken to announce that D’Angelo, recognized by his followers around the globe as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his pioneering modern soul style and collaborations with renowned musicians.

He launched his first record, “Brown Sugar,” in 1995 to instant praise. The record achieved the fourth spot on Billboard’s Top R&B Albums chart, went platinum soon after, and received multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his artistic journey into the stratosphere. The album debuted at No. 1 on each of the R&B charts and the main album chart. He won two Grammy Awards: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a reluctant one, in the cultural zeitgeist. The personal depiction showed the singer, notably stripped down to his waist, performing straight into the camera.

D’Angelo stepped back from the public eye after putting out Voodoo and publicly struggled with substance abuse. In 2005, he was involved in a severe car crash that put him in critical condition.

More than a decade later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with a further No. 1 debut on the R&B chart and a award for Top R&B Record.

Once more, in his own mysterious way, D’Angelo made only a few public appearances in the subsequent period.

The musician was announced as a headliner for the 2025 Roots Picnic festival, but his performance was called off, citing an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s well-being in the weeks before his passing, he had apparently been hospitalized for months and in palliative care for a fortnight.

D’Angelo’s passing is a stark reminder of the devastating effects of pancreatic malignancy, one of the deadliest and least preventable forms of the illness, on a gifted artist whose life was cut short.

“We are grieved that he can only provide cherished moments with his loved ones, but we are eternally grateful for the legacy of deeply emotional songs he has left us,” his family expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic cancer affects the pancreas, a small organ that generates the hormone insulin and is vital in digestion, among other functions. The size and location of the pancreas in the human system make it more challenging to detect malignancy.

Although this cancer makes up only about 3% of cancer diagnoses each year in the U.S., it is responsible for seven percent of cancer deaths.

Almost 70,000 individuals will be found to have pancreatic cancer and about fifty-two thousand will die of the disease in the year 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have limited and poor therapies, and a smaller window to make a significant difference on the well-being of patients,” noted a cancer specialist.

Since pancreatic cancer rarely causes early symptoms, it’s frequently identified only once the disease is advanced. Although a patient has symptoms they are often nonspecific and may be confused with a several common illnesses.

“As of yet, there is no effective method to detect pancreatic cancer in the early stages, except for listening to your body and speaking with your doctor if there are new or unusual signs,” explained a medical director.

Frequent indicators of pancreatic cancer encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• reduced hunger
• brownish urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• nausea

At 51 years old, D’Angelo’s demise is an outlier, as pancreatic cancer is most common in individuals in the 65 to 75 age bracket. However, numerous malignancies, such as this type, have become increasingly prevalent among younger people.

“This disease diagnosed before the age of 50 is considered uncommon, yet alarmingly, clinicians are noticing a rising count of younger individuals affected by this condition,” commented a expert.

Family History Affects Disease Probability

In the absence of reliable detection methods for this malignancy, professionals emphasized the importance of knowing your relatives’ health background. Some risk factors, such as smoking and excess weight also have an influence in the onset of this disease.

Black individuals have the greatest occurrence of this malignancy in the U.S. and are most likely to be diagnosed with untreatable disease.

“The first step toward reducing one’s risk of pancreatic cancer is assessing individual susceptibility. Individuals should review their family history, genetic background, and medical conditions, such as blood sugar disease, chronic pancreatitis, or obesity that may raise their susceptibility,” said a specialist.

Hereditary risk factors are linked to as much as 10% of all this malignancy cases. If someone in your family has had this disease, you may want to think about DNA analysis.

“For people with a family history of this condition or those having elevated risk genetic mutations, checking may involve sophisticated scans such as MRI scans or endoscopic ultrasound (EUS) to detect initial alterations in the pancreas,” he clarified.

For those wishing to reduce their risk, lifestyle changes may have an effect. The most effective step you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you are a non-smoker, avoid exposure altogether.

Heavy drinking is linked to pancreas inflammation, a risk factor for pancreatic cancer, so limiting or abstaining from drinks may help reduce your risk.

Managing your weight or losing weight may also aid reduce your risk. People with obesity are 20% more likely to get this disease. This malignancy also is more frequent in people with blood sugar issues, and reducing weight can also reduce the risk of type 2 diabetes.

In spite of pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and newer mixed drug treatments. There are emerging targeted therapies that are already showing results,” remarked a expert.

For numerous individuals, however, education about this rare but {dev